login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
RAFAEL HOLDINGS INC-CLASS B (RFL) Stock News
NYSE:RFL -
US75062E1064
-
Common Stock
1.47
USD
-0.09 (-5.77%)
Last: 8/25/2025, 8:04:00 PM
1.44
USD
-0.03 (-2.04%)
After Hours:
8/25/2025, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RFL Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Benzinga
- Mentions:
CYCC
CRL
ONMD
HCTI
...
12 Health Care Stocks Moving In Monday's After-Market Session
2 months ago - By: Benzinga
- Mentions:
GOVX
GALT
APVO
CELZ
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
2 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
2 months ago - By: Rafael Holdings, Inc.
- Mentions:
NYSE
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
3 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
3 months ago - By: Rafael Holdings, Inc.
- Mentions:
NYSE
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
3 months ago - By: Rafael Holdings, Inc.
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
3 months ago - By: Rafael Holdings, Inc.
- Mentions:
NYSE
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
3 months ago - By: Rafael Holdings, Inc.
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of
3 months ago - By: Rafael Holdings, Inc.
- Mentions:
NYSE
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of
4 months ago - By: Rafael Holdings, Inc.
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
4 months ago - By: Rafael Holdings, Inc.
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
4 months ago - By: Rafael Holdings, Inc.
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
4 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role
4 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role
5 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
5 months ago - By: Rafael Holdings, Inc.
- Mentions:
CYTH
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
6 months ago - By: Rafael Holdings, Inc.
- Mentions:
CYTH
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results
6 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results
9 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
9 months ago - By: Rafael Holdings, Inc.
- Mentions:
CYTH
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
10 months ago - By: Rafael Holdings, Inc.
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
10 months ago - By: Rafael Holdings, Inc.
- Mentions:
CYTH
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
a year ago - By: Halper Sadeh LLC
- Mentions:
CDE
SMC
COFS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, SMC, COFS, RFL on Behalf of Shareholders
a year ago - By: Halper Sadeh LLC
- Mentions:
BTTR
RVNC
ARC
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, RVNC, ARC, RFL on Behalf of Shareholders
Please enable JavaScript to continue using this application.